Determinants of COVID-19 Vaccine Acceptance Among Nigerian Adults

Author(s)

Afolayan O1, Olateju OA2, Adekunle YA3
1The University of Texas Health Science Center at Houston, Houston, TX, USA, 2University of Houston, Houston, TX, USA, 3University of Ibadan, Ibadan, Oyo, Nigeria

OBJECTIVES: The objective of this study is to describe the current vaccine acceptance landscape in Nigeria and to evaluate factors associated with COVID-19 vaccine acceptance uptake in Nigeria.

METHODS: A cross-sectional study was conducted in which participants aged 18 and above provided their socio-demographic information, perceived threats and exposure to COVID-19, perception about vaccines, and willingness to receive COVID vaccine through a web-based questionnaire with validated instruments. Oral interview was conducted for participants who are not able to use the internet. Descriptive statistics was used to describe the distribution of participants and multivariable logistic regression was used to determine the odds of participant’s willingness to receive the vaccine given the participant’s characteristics described above.

RESULTS: Majority (70.1%) of respondents had not received the vaccine and only 40.5% of them reported that they are willing to receive the vaccine. About half (52.6%) of respondents reported that were at high risk of COVID-19 and about one-third (67.0%) reported that vaccines are safe and effective. Only having COVID in the past showed a statistically significant association with willingness to receive COVID-19 vaccine (OR = 0.63; 95% CI = 0.369-1.076)

CONCLUSIONS: Vaccine acceptance is still low and only those who had COVID are likely to receive the vaccine. There is need for increased sensitization of the public to the importance of receiving the vaccine to contain the disease on a global scale.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)

Code

EPH37

Topic

Epidemiology & Public Health

Topic Subcategory

Public Health

Disease

Vaccines

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×